Project Name: Greater Manchester Cancer Care Alliance -Cancer Care Coordinators within Breast Oncology services

Project Summary:

The Collaborative Working Project (“CWP”) aims to maximise efficiency to optimise workforce capacity within the Greater Manchester (“GM”) breast cancer (“BC”) oncology service with the creation of a new dedicated workforce role of four Breast cancer care coordinators for two years. The intention is to maximise efficiency of clinical appointments that will improve the pathway for patients providing a more efficient and co-ordinated approach to their care.

Amendment July 2025 to allow for extended timeline due to an initial delay in recruiting the posts and onboarding the breast cancer care coordinators.

Planned Milestones:

Milestone

Description

1

Kick-off meeting 

2

Recruitment of the CWP Roles.

3

Onboarding of CWP Roles. Baseline data. Develop protocols. 

4

Pathway mapping of the Greater Manchester (GM) Systemic Anti-Cancer Therapy (SACT) delivery service.

5

Carry out 3 months of clinical operations according to the developed protocols.   

6

Develop business case to support future funding post project.

7

Carry out 6 months of clinical operations according to the developed protocols. 

8

Project Manager to share interim outputs with the GM Cancer Alliance to share  with the other 20 Cancer Care alliance Leads.

9

Carry out 9 months of clinical operations according to the developed protocols.   

10

Carry out 12 months of clinical operations according to the developed protocols.

11

Carry out 15 months of clinical operations according to the developed protocols.

12

Carry out 18 months of clinical operations according to the developed protocols.

13

Submit final CWP report to Novartis. Develop with Novartis the outcomes summary and  publishing in line with the ABPI guidelines.

 

Expected Benefits:

ANTICIPATED BENEFITS FOR PATIENTS

  • Named NHS Project Managerco-ordinating BC care will improve patient experience of the BC service by coordinating the patients Cancer care appointments.
  • More streamlined pathway to improve the patient experience and limit visits to the hospital.

ANTICIPATED BENEFITS FOR THE ORGANISATION(S)

  • Workforce efficiency and optimisation by removing administrative burden from clinical staff and coordinating patient care.
  • Increased clinic efficiency by ensuring all up to date tests results are available at the right time.
  • Increase the overall quality of care and improve equity of access to specialist care for patients with BC requiring treatment initiation, evaluation, and monitoring.
  • Provide a single point of contact for patients, thereby reducing the potential for unplanned calls being received by the wider clinical team.
  • Free up consultant capacity for clinical activities that are unique to their skillset.
  • CWP would highlight GM cancer Care Alliance and The Christies  as an exemplar in service re-design of worksforce optimisation and sustainability.

ANTICIPATED BENEFITS FOR NOVARTIS

  • Better understanding of overall HCP and patient needs.
  • Optimal use of medicines in line with local/national guidance (including Novartis medicines) in appropriate patients.
  • Ethical, professional, and transparent relationship between Novartis and the Healthcare Organisations.

Start Date & Duration: Start date, October 2023.,CWP amended July 2025. Project duration 37 months.

FA-11504794 | September 2025